Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
Near-patient testing (NPT) allows clinical decisions to be made in a rapid and convenient manner and is often cost effective. In COPD the peripheral blood eosinophil count has been demonstrated to have utility in providing prognostic information and predicting response to treatment during an acute e...
Κύριοι συγγραφείς: | Hambleton, K, Connolly, C, Borg, C, Davies, J, Jeffers, H, Russell, R, Bafadhel, M |
---|---|
Μορφή: | Journal article |
Έκδοση: |
Dove Press
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
ανά: Hambleton, K, κ.ά.
Έκδοση: (2016) -
The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2017) -
Characterising non-eosinophilic COPD
ανά: Hambleton, K, κ.ά.
Έκδοση: (2015) -
Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
ανά: Jeffers, H, κ.ά.
Έκδοση: (2017) -
Investigating blood eosinophil count thresholds in patients with COPD
ανά: Russell, R, κ.ά.
Έκδοση: (2018)